ロード中...
Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)
Glioblastoma (GBM) is a highly aggressive primary brain tumor with dismal outcome for affected patients. Because of the significant neo-angiogenesis exhibited by GBMs, anti-angiogenic therapies have been intensively evaluated during the past years. Recent clinical studies were however disappointing,...
保存先:
| 出版年: | Mol Cell Proteomics |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The American Society for Biochemistry and Molecular Biology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4739668/ https://ncbi.nlm.nih.gov/pubmed/26243272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M115.052423 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|